Skip to main content
Top
Published in: BMC Gastroenterology 1/2009

Open Access 01-12-2009 | Research article

Visceral obesity and the risk of Barrett's esophagus in Japanese patients with non-alcoholic fatty liver disease

Authors: Tomoyuki Akiyama, Masato Yoneda, Masahiko Inamori, Hiroshi Iida, Hiroki Endo, Kunihiro Hosono, Kyoko Yoneda, Koji Fujita, Tomoko Koide, Chikako Tokoro, Hirokazu Takahashi, Ayumu Goto, Yasunobu Abe, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima

Published in: BMC Gastroenterology | Issue 1/2009

Login to get access

Abstract

Background

The association between obesity and the risk of Barrett's esophagus (BE) is unclear. Furthermore, the association between visceral obesity and the risk of BE is entirely unknown.

Methods

We conducted a retrospective study in 163 patients with non-alcoholic fatty liver disease (NAFLD) who underwent both endoscopy and abdominal CT at an interval of less than a year at our institution. BE was endoscopically diagnosed based on the Prague C & M Criteria. The surface areas of visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) were calculated from CT images at the level of the umbilicus. The correlations between the BMI, VAT, and SAT and the risk of BE were examined by univariate and multivariate analyses.

Results

Sixty-nine of the 163 study participants (42.3%) were diagnosed to have endoscopic BE, which was classified as short-segment BE (SSBE) in almost all of the cases. There were no significant differences in the age or gender distribution between the groups with and without BE. According to the results of the univariate analysis, VAT was significantly associated with the risk of BE; the BMI tended to be higher in the group with BE than in the group without BE, but this relation did not reach statistical significance. VAT was independently associated with the risk of BE even after adjustment for the BMI.

Conclusion

In Japanese patients with NAFLD, obesity tended to be associated with the risk of BE, and this risk appeared to be mediated for the most part by abdominal visceral adiposity.
Literature
1.
go back to reference Boyko EJ, Fujimoto WY, Leonetti DL, Newell-Morris L: Visceral adiposity and risk of type 2 diabetes: A prospective study among Japanese Americans. Diabetes Care. 2000, 23: 465-71. 10.2337/diacare.23.4.465.CrossRefPubMed Boyko EJ, Fujimoto WY, Leonetti DL, Newell-Morris L: Visceral adiposity and risk of type 2 diabetes: A prospective study among Japanese Americans. Diabetes Care. 2000, 23: 465-71. 10.2337/diacare.23.4.465.CrossRefPubMed
2.
go back to reference Dalton M, Cameron AJ, Zimmet PZ, Shaw JE, Jolley D, Dunstan DW, Welborn TA, AusDiab Steering Committee: Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med. 2003, 254: 555-63. 10.1111/j.1365-2796.2003.01229.x.CrossRefPubMed Dalton M, Cameron AJ, Zimmet PZ, Shaw JE, Jolley D, Dunstan DW, Welborn TA, AusDiab Steering Committee: Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med. 2003, 254: 555-63. 10.1111/j.1365-2796.2003.01229.x.CrossRefPubMed
3.
go back to reference Angulo P: Nonalcoholic fatty liver disease. N Engl J Med. 2002, 346: 1221-1231. 10.1056/NEJMra011775.CrossRefPubMed Angulo P: Nonalcoholic fatty liver disease. N Engl J Med. 2002, 346: 1221-1231. 10.1056/NEJMra011775.CrossRefPubMed
4.
go back to reference Poorten van der D, Milner KL, Hui J, Hodge A, Trenell MI, Kench JG, London R, Peduto T, Chisholm DJ, George J: Visceral Fat: A Key Mediator of Steatohepatitis in Metabolic Liver Disease. Hepatology. 2008, 48: 449-57. 10.1002/hep.22350.CrossRefPubMed Poorten van der D, Milner KL, Hui J, Hodge A, Trenell MI, Kench JG, London R, Peduto T, Chisholm DJ, George J: Visceral Fat: A Key Mediator of Steatohepatitis in Metabolic Liver Disease. Hepatology. 2008, 48: 449-57. 10.1002/hep.22350.CrossRefPubMed
5.
go back to reference Dent J, El-Serag HB, Wallander MA, Johansson S: Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005, 54: 710-7. 10.1136/gut.2004.051821.CrossRefPubMedPubMedCentral Dent J, El-Serag HB, Wallander MA, Johansson S: Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005, 54: 710-7. 10.1136/gut.2004.051821.CrossRefPubMedPubMedCentral
6.
go back to reference van Soest EM, Dieleman JP, Siersema PD, et al: Increasing incidence of Barrett's oesophagus in the general population. Gut. 2005, 54: 1062-6. 10.1136/gut.2004.063685.CrossRefPubMedPubMedCentral van Soest EM, Dieleman JP, Siersema PD, et al: Increasing incidence of Barrett's oesophagus in the general population. Gut. 2005, 54: 1062-6. 10.1136/gut.2004.063685.CrossRefPubMedPubMedCentral
7.
go back to reference Bollschweiler E, Wolfgarten E, Gutschow C, Holscher AH: Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer. 2001, 92: 549-55. 10.1002/1097-0142(20010801)92:3<549::AID-CNCR1354>3.0.CO;2-L.CrossRefPubMed Bollschweiler E, Wolfgarten E, Gutschow C, Holscher AH: Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer. 2001, 92: 549-55. 10.1002/1097-0142(20010801)92:3<549::AID-CNCR1354>3.0.CO;2-L.CrossRefPubMed
8.
go back to reference Flegal KM, Carroll MD, Ogden CL, Johnson CL: Prevalence and trends in obesity among US adults, 1999–2000. JAMA. 2002, 288: 1723-7. 10.1001/jama.288.14.1723.CrossRefPubMed Flegal KM, Carroll MD, Ogden CL, Johnson CL: Prevalence and trends in obesity among US adults, 1999–2000. JAMA. 2002, 288: 1723-7. 10.1001/jama.288.14.1723.CrossRefPubMed
9.
go back to reference Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM: Prevalence of overweight and obesity in the United States, 1999–2004. JAMA. 2006, 295: 1549-55. 10.1001/jama.295.13.1549.CrossRefPubMed Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM: Prevalence of overweight and obesity in the United States, 1999–2004. JAMA. 2006, 295: 1549-55. 10.1001/jama.295.13.1549.CrossRefPubMed
10.
go back to reference Locke GR, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ: Risk factors associated with symptoms of gastroesophageal reflux. Am J Med. 1999, 106: 642-9. 10.1016/S0002-9343(99)00121-7.CrossRefPubMed Locke GR, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ: Risk factors associated with symptoms of gastroesophageal reflux. Am J Med. 1999, 106: 642-9. 10.1016/S0002-9343(99)00121-7.CrossRefPubMed
11.
go back to reference Ruhl CE, Everhart JE: Overweight, but not high dietary fat intake, increases risk of gastroesophageal reflux disease hospitalization: the NHANES Epidemiologic Followup Study. First National Health and Nutrition Examination Survey. Ann Epidemiol. 1999, 9: 424-35. 10.1016/S1047-2797(99)00020-4.CrossRefPubMed Ruhl CE, Everhart JE: Overweight, but not high dietary fat intake, increases risk of gastroesophageal reflux disease hospitalization: the NHANES Epidemiologic Followup Study. First National Health and Nutrition Examination Survey. Ann Epidemiol. 1999, 9: 424-35. 10.1016/S1047-2797(99)00020-4.CrossRefPubMed
12.
go back to reference El-Serag HB, Graham DY, Satia JA, Rabeneck L: Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol. 2005, 100: 1243-50. 10.1111/j.1572-0241.2005.41703.x.CrossRefPubMed El-Serag HB, Graham DY, Satia JA, Rabeneck L: Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol. 2005, 100: 1243-50. 10.1111/j.1572-0241.2005.41703.x.CrossRefPubMed
13.
go back to reference Nandurkar S, Locke GR, Fett S, Zinsmeister AR, Cameron AJ, Talley NJ: Relationship between body mass index, diet, exercise and gastro-oesophageal reflux symptoms in a community. Aliment Pharmacol Ther. 2004, 20: 497-505. 10.1111/j.1365-2036.2004.02156.x.CrossRefPubMed Nandurkar S, Locke GR, Fett S, Zinsmeister AR, Cameron AJ, Talley NJ: Relationship between body mass index, diet, exercise and gastro-oesophageal reflux symptoms in a community. Aliment Pharmacol Ther. 2004, 20: 497-505. 10.1111/j.1365-2036.2004.02156.x.CrossRefPubMed
14.
go back to reference Kubo A, Corley DA: Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006, 15: 872-878. 10.1158/1055-9965.EPI-05-0860.CrossRefPubMed Kubo A, Corley DA: Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006, 15: 872-878. 10.1158/1055-9965.EPI-05-0860.CrossRefPubMed
15.
go back to reference El-Serag HB, Kvapil P, Hacken-Bitar J, Kramer JR: Abdominal obesity and the risk of Barrett's esophagus. Am J Gastroenterol. 2005, 100: 2151-6. 10.1111/j.1572-0241.2005.00251.x.CrossRefPubMed El-Serag HB, Kvapil P, Hacken-Bitar J, Kramer JR: Abdominal obesity and the risk of Barrett's esophagus. Am J Gastroenterol. 2005, 100: 2151-6. 10.1111/j.1572-0241.2005.00251.x.CrossRefPubMed
16.
go back to reference Stein DJ, El-Serag HB, Kuczynski J, Kramer JR, Sampliner RE: The association of body mass index with Barrett's oesophagus. Aliment Pharmacol Ther. 2005, 22: 1005-10. 10.1111/j.1365-2036.2005.02674.x.CrossRefPubMed Stein DJ, El-Serag HB, Kuczynski J, Kramer JR, Sampliner RE: The association of body mass index with Barrett's oesophagus. Aliment Pharmacol Ther. 2005, 22: 1005-10. 10.1111/j.1365-2036.2005.02674.x.CrossRefPubMed
17.
go back to reference Smith KJ, O'Brien SM, Smithers BM, Gotley DC, Webb PM, Green AC, Whiteman DC: Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev. 2005, 14: 2481-6. 10.1158/1055-9965.EPI-05-0370.CrossRefPubMedPubMedCentral Smith KJ, O'Brien SM, Smithers BM, Gotley DC, Webb PM, Green AC, Whiteman DC: Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev. 2005, 14: 2481-6. 10.1158/1055-9965.EPI-05-0370.CrossRefPubMedPubMedCentral
18.
go back to reference Gerson LB, Ullah N, Fass R, Green C, Shetler K, Singh G: Does body mass index differ between patients with Barrett's esophagus and patients with chronic gastroesophageal reflux disease?. Aliment Pharmacol Ther. 2007, 25: 1079-86.CrossRefPubMed Gerson LB, Ullah N, Fass R, Green C, Shetler K, Singh G: Does body mass index differ between patients with Barrett's esophagus and patients with chronic gastroesophageal reflux disease?. Aliment Pharmacol Ther. 2007, 25: 1079-86.CrossRefPubMed
19.
go back to reference Corley DA, Kubo A, Levin TR, Block G, Habel L, Zhao W, Leighton P, Quesenberry C, Rumore GJ, Buffler PA: Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology. 2007, 133: 34-41. 10.1053/j.gastro.2007.04.046.CrossRefPubMed Corley DA, Kubo A, Levin TR, Block G, Habel L, Zhao W, Leighton P, Quesenberry C, Rumore GJ, Buffler PA: Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology. 2007, 133: 34-41. 10.1053/j.gastro.2007.04.046.CrossRefPubMed
20.
go back to reference Edelstein ZR, Farrow DC, Bronner MP, Rosen SN, Vaughan TL: Central adiposity and risk of Barrett's esophagus. Gastroenterology. 2007, 133: 403-11. 10.1053/j.gastro.2007.05.026.CrossRefPubMed Edelstein ZR, Farrow DC, Bronner MP, Rosen SN, Vaughan TL: Central adiposity and risk of Barrett's esophagus. Gastroenterology. 2007, 133: 403-11. 10.1053/j.gastro.2007.05.026.CrossRefPubMed
21.
go back to reference John BJ, Irukulla S, Abulafi AM, Kumar D, Mendall MA: Systematic review: adipose tissue, obesity and gastrointestinal diseases. Aliment Pharmacol Ther. 2006, 23: 1511-23. 10.1111/j.1365-2036.2006.02915.x.CrossRefPubMed John BJ, Irukulla S, Abulafi AM, Kumar D, Mendall MA: Systematic review: adipose tissue, obesity and gastrointestinal diseases. Aliment Pharmacol Ther. 2006, 23: 1511-23. 10.1111/j.1365-2036.2006.02915.x.CrossRefPubMed
22.
go back to reference Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996, 334: 292-5. 10.1056/NEJM199602013340503.CrossRefPubMed Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996, 334: 292-5. 10.1056/NEJM199602013340503.CrossRefPubMed
23.
go back to reference Ogunwobi O, Mutungi G, Beales IL: Leptin stimulates proliferation and inhibits apotosis in Barrett's esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation. Endocrinology. 2006, 147: 4505-16. 10.1210/en.2006-0224.CrossRefPubMed Ogunwobi O, Mutungi G, Beales IL: Leptin stimulates proliferation and inhibits apotosis in Barrett's esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation. Endocrinology. 2006, 147: 4505-16. 10.1210/en.2006-0224.CrossRefPubMed
24.
go back to reference Kendall BJ, Macdonald GA, Hayward NK, Prins JB, Brown I, Walker N, Pandeya N, Green AC, Webb PM, Whiteman DC, Study of Digestive Health: Leptin and the risk of Barrett's oesophagus. Gut. 2008, 57: 448-54. 10.1136/gut.2007.131243.CrossRefPubMed Kendall BJ, Macdonald GA, Hayward NK, Prins JB, Brown I, Walker N, Pandeya N, Green AC, Webb PM, Whiteman DC, Study of Digestive Health: Leptin and the risk of Barrett's oesophagus. Gut. 2008, 57: 448-54. 10.1136/gut.2007.131243.CrossRefPubMed
25.
26.
go back to reference Rubenstein JH, Dahlkemper A, Kao JY, Zhang M, Morgenstern H, McMahon L, Inadomi JM: A Pilot Study of the Association of Low Plasma Adiponectin and Barrett's Esophagus. Am J Gastroenterol. 2008, 103: 1358-64. 10.1111/j.1572-0241.2008.01823.x.CrossRefPubMed Rubenstein JH, Dahlkemper A, Kao JY, Zhang M, Morgenstern H, McMahon L, Inadomi JM: A Pilot Study of the Association of Low Plasma Adiponectin and Barrett's Esophagus. Am J Gastroenterol. 2008, 103: 1358-64. 10.1111/j.1572-0241.2008.01823.x.CrossRefPubMed
27.
go back to reference Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmiche JP, Lundell L, Margulies M, Richter JE, Spechler SJ, Tytgat GN, Wallin L: The endoscopic assessment of esophagitis: A progress report on observer agreement. Gastroenterology. 1996, 111: 85-92. 10.1053/gast.1996.v111.pm8698230.CrossRefPubMed Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmiche JP, Lundell L, Margulies M, Richter JE, Spechler SJ, Tytgat GN, Wallin L: The endoscopic assessment of esophagitis: A progress report on observer agreement. Gastroenterology. 1996, 111: 85-92. 10.1053/gast.1996.v111.pm8698230.CrossRefPubMed
28.
go back to reference Sharma P, Dent J, Armstrong D, Bergman JJGHM, Gossner L, Hoshihara Y, Jankowski JA, Junghard O, Lundell L, Tytgat GNJ, Vieth M: The Development and Validation of an Endoscopic Grading System for Barrett's Esophagus: The Prague C & M Criteria. Gastroenterology. 2006, 131: 1392-1399. 10.1053/j.gastro.2006.08.032.CrossRefPubMed Sharma P, Dent J, Armstrong D, Bergman JJGHM, Gossner L, Hoshihara Y, Jankowski JA, Junghard O, Lundell L, Tytgat GNJ, Vieth M: The Development and Validation of an Endoscopic Grading System for Barrett's Esophagus: The Prague C & M Criteria. Gastroenterology. 2006, 131: 1392-1399. 10.1053/j.gastro.2006.08.032.CrossRefPubMed
29.
go back to reference Amano Y, Kushiyama Y, Yuki T, Takahashi Y, Moriyama I, Fukuhara H, Ishimura N, Furuta K, Ishihara S, Adachi K, Maruyama R, Kinoshita Y: Prevalence of and risk factors for Barrett's esophagus with intestinal predominant mucin phenotype. Scand J Gastroenterol. 2006, 41: 873-9.CrossRefPubMed Amano Y, Kushiyama Y, Yuki T, Takahashi Y, Moriyama I, Fukuhara H, Ishimura N, Furuta K, Ishihara S, Adachi K, Maruyama R, Kinoshita Y: Prevalence of and risk factors for Barrett's esophagus with intestinal predominant mucin phenotype. Scand J Gastroenterol. 2006, 41: 873-9.CrossRefPubMed
30.
go back to reference Akiyama T, Inamori M, Akimoto K, Iida H, Mawatari H, Endo H, Ikeda T, Nozaki Y, Yoneda K, Sakamoto Y, Fujita K, Yoneda M, Takahashi H, Hirokawa S, Goto A, Abe Y, Kirikoshi H, Kobayashi N, Kubota K, Saito S, Nakajima A: Risk Factors for the Progression of Endoscopic Barrett's Epithelium in Japan: A Multivariate Analysis Based on the Prague C & M Criteria. Dig Dis Sci. 2009, 54: 1702-7. 10.1007/s10620-008-0537-y.CrossRefPubMed Akiyama T, Inamori M, Akimoto K, Iida H, Mawatari H, Endo H, Ikeda T, Nozaki Y, Yoneda K, Sakamoto Y, Fujita K, Yoneda M, Takahashi H, Hirokawa S, Goto A, Abe Y, Kirikoshi H, Kobayashi N, Kubota K, Saito S, Nakajima A: Risk Factors for the Progression of Endoscopic Barrett's Epithelium in Japan: A Multivariate Analysis Based on the Prague C & M Criteria. Dig Dis Sci. 2009, 54: 1702-7. 10.1007/s10620-008-0537-y.CrossRefPubMed
31.
go back to reference Watson A, Heading RC, Shepherd NA: Guidelines for the diagnosis and management of Barrett's columnar-lined oesophagus A Report of the Working Party of the British Society of Gastroenterology. 2005, British Society of Gastroenterology, London, UK Watson A, Heading RC, Shepherd NA: Guidelines for the diagnosis and management of Barrett's columnar-lined oesophagus A Report of the Working Party of the British Society of Gastroenterology. 2005, British Society of Gastroenterology, London, UK
32.
go back to reference Sharma P, Morales TG, Sampliner RE: Short segment Barrett's esophagus: the need for standardization of the definition and of endoscopic criteria. Am J Gastroenterol. 1998, 93: 1033-66.PubMed Sharma P, Morales TG, Sampliner RE: Short segment Barrett's esophagus: the need for standardization of the definition and of endoscopic criteria. Am J Gastroenterol. 1998, 93: 1033-66.PubMed
33.
go back to reference Hamilton ST, Smith RR: The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. Am J Clin Pathol. 1987, 87: 301-12.CrossRefPubMed Hamilton ST, Smith RR: The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. Am J Clin Pathol. 1987, 87: 301-12.CrossRefPubMed
34.
go back to reference Weinsier RL, Hunter GR, Gower BA, Schutz Y, Darnell BE, Zuckerman PA: Body fat distribution in white and black women: Different patterns of intraabdominal and subcutaneous abdominal adipose tissue utilization with weight loss. Am J Clin Nutr. 2001, 74: 631-6.PubMed Weinsier RL, Hunter GR, Gower BA, Schutz Y, Darnell BE, Zuckerman PA: Body fat distribution in white and black women: Different patterns of intraabdominal and subcutaneous abdominal adipose tissue utilization with weight loss. Am J Clin Nutr. 2001, 74: 631-6.PubMed
35.
go back to reference El-Serag HB, Mason AC, Petersen N, Key CR: Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut. 2002, 50: 368-72. 10.1136/gut.50.3.368.CrossRefPubMedPubMedCentral El-Serag HB, Mason AC, Petersen N, Key CR: Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut. 2002, 50: 368-72. 10.1136/gut.50.3.368.CrossRefPubMedPubMedCentral
36.
go back to reference Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003, 348: 1625-38. 10.1056/NEJMoa021423.CrossRefPubMed Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003, 348: 1625-38. 10.1056/NEJMoa021423.CrossRefPubMed
37.
go back to reference Calle EE, Kaaks R: Overweight, obesity, and cancer: Epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004, 4: 579-91. 10.1038/nrc1408.CrossRefPubMed Calle EE, Kaaks R: Overweight, obesity, and cancer: Epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004, 4: 579-91. 10.1038/nrc1408.CrossRefPubMed
38.
go back to reference El-Serag HB, Ergun GA, Pandolfino J, Fitzgerald S, Tran T, Kramer JR: Obesity increases esophageal acid exposure. Gut. 2007, 56: 749-55. 10.1136/gut.2006.100263.CrossRefPubMed El-Serag HB, Ergun GA, Pandolfino J, Fitzgerald S, Tran T, Kramer JR: Obesity increases esophageal acid exposure. Gut. 2007, 56: 749-55. 10.1136/gut.2006.100263.CrossRefPubMed
39.
go back to reference Ford ES, Mokdad AH, Giles WH: Trends in waist circumference among U.S. adults. Obes Res. 2003, 11: 1223-31. 10.1038/oby.2003.168.CrossRefPubMed Ford ES, Mokdad AH, Giles WH: Trends in waist circumference among U.S. adults. Obes Res. 2003, 11: 1223-31. 10.1038/oby.2003.168.CrossRefPubMed
40.
go back to reference Kooy van der K, Leenen R, Seidell JC, Deurenberg P, Droop A, Bakker CJ: Waist-hip ratio is a poor predictor of changes in visceral fat. Am J Clin Nutr. 1993, 57: 327-33.PubMed Kooy van der K, Leenen R, Seidell JC, Deurenberg P, Droop A, Bakker CJ: Waist-hip ratio is a poor predictor of changes in visceral fat. Am J Clin Nutr. 1993, 57: 327-33.PubMed
41.
go back to reference Seidell JC, Oosterlee A, Deurenberg P, Hautvast JG, Ruijs JH: Abdominal fat depots measured with computed tomography: Effects of degree of obesity, sex, and age. Eur J Clin Nutr. 1988, 42: 805-15.PubMed Seidell JC, Oosterlee A, Deurenberg P, Hautvast JG, Ruijs JH: Abdominal fat depots measured with computed tomography: Effects of degree of obesity, sex, and age. Eur J Clin Nutr. 1988, 42: 805-15.PubMed
42.
go back to reference Baumgartner RN, Heymsfield SB, Roche AF, Bernardino M: Abdominal composition quantified by computed tomography. Am J Clin Nutr. 1988, 48: 936-45.PubMed Baumgartner RN, Heymsfield SB, Roche AF, Bernardino M: Abdominal composition quantified by computed tomography. Am J Clin Nutr. 1988, 48: 936-45.PubMed
Metadata
Title
Visceral obesity and the risk of Barrett's esophagus in Japanese patients with non-alcoholic fatty liver disease
Authors
Tomoyuki Akiyama
Masato Yoneda
Masahiko Inamori
Hiroshi Iida
Hiroki Endo
Kunihiro Hosono
Kyoko Yoneda
Koji Fujita
Tomoko Koide
Chikako Tokoro
Hirokazu Takahashi
Ayumu Goto
Yasunobu Abe
Hiroyuki Kirikoshi
Noritoshi Kobayashi
Kensuke Kubota
Satoru Saito
Atsushi Nakajima
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2009
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-9-56

Other articles of this Issue 1/2009

BMC Gastroenterology 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.